Growth Metrics

Orthopediatrics (KIDS) Capital Expenditures (2016 - 2026)

Orthopediatrics has reported Capital Expenditures over the past 11 years, most recently at $1.8 million for Q1 2026.

  • For Q1 2026, Capital Expenditures fell 58.36% year-over-year to $1.8 million; the TTM value through Mar 2026 reached $8.6 million, up 487.06%, while the annual FY2025 figure was $11.1 million, N/A changed from the prior year.
  • Capital Expenditures for Q1 2026 was $1.8 million at Orthopediatrics, up from $599000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $6.7 million in Q2 2024 and troughed at -$14.5 million in Q4 2024.
  • A 5-year average of $789176.5 and a median of $2.8 million in 2025 define the central range for Capital Expenditures.
  • On a YoY basis, Capital Expenditures climbed as much as 205.39% in 2022 and fell as far as 745.5% in 2022.
  • Year by year, Capital Expenditures stood at -$10.6 million in 2022, then dropped by 18.4% to -$12.5 million in 2023, then dropped by 16.24% to -$14.5 million in 2024, then soared by 104.12% to $599000.0 in 2025, then soared by 193.82% to $1.8 million in 2026.
  • Business Quant data shows Capital Expenditures for KIDS at $1.8 million in Q1 2026, $599000.0 in Q4 2025, and $2.8 million in Q3 2025.